Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) EBT: 2019-2024

Historic EBT for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Dec 2024 value amounting to $191.8 million.

  • Harmony Biosciences Holdings' EBT rose 8.56% to $67.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $230.5 million, marking a year-over-year increase of 31.44%. This contributed to the annual value of $191.8 million for FY2024, which is 10.62% up from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported EBT of $191.8 million as of FY2024, which was up 10.62% from $173.4 million recorded in FY2023.
  • In the past 5 years, Harmony Biosciences Holdings' EBT registered a high of $191.8 million during FY2024, and its lowest value of -$36.9 million during FY2020.
  • Moreover, its 3-year median value for EBT was $173.4 million (2023), whereas its average is $156.6 million.
  • Data for Harmony Biosciences Holdings' EBT shows a peak YoY spiked of 201.31% (in 2021) over the last 5 years.
  • Harmony Biosciences Holdings' EBT (Yearly) stood at -$36.9 million in 2020, then soared by 201.31% to $37.4 million in 2021, then skyrocketed by 179.70% to $104.7 million in 2022, then surged by 65.63% to $173.4 million in 2023, then increased by 10.62% to $191.8 million in 2024.